Feature

Research Reports

Can We Fill in the Gaps? Authoring Custom Oncology Pathways vs Surfacing NCCN Preferred Recommendations Alone

06/05/2023

Rebecca Maniago, PharmD, and colleagues compare the overall availability of NCCN Preferred recommendations to custom preferred pathways and assess provider concordance with the preferred suggestions, particularly those encountered in the...

Rebecca Maniago, PharmD, and...

06/05/2023

Journal of Clinical Pathways

Research Reports

Treatment Duration, Adherence, Interruptions, and Discontinuations Associated With Maintenance Regimens for Recurrent Ovarian Cancer

06/05/2023

Scott H. Bunner , MPH;

Allison M. Saiz , MD;

Nicole M. Engel-Nitz , PhD;

Emma L. Barber , MD;

Katrine L. Wallace , PhD;

Emma L. Barber, MD, and colleagues investigate current and real-world practice patterns for patients receiving maintenance therapy for recurrent ovarian cancer after second-line chemotherapy.

Emma L. Barber, MD, and...

06/05/2023

Journal of Clinical Pathways

Research Reports

Pegfilgrastim Home Redirection Outcomes: Effectiveness and Timing of Administration in Primary Prophylaxis of Chemotherapy-Induced Neutropenia

06/05/2023

Lavanya Raj , MBBS, MS;

Pam McManus ;

Lavanya Raj, MBBS, MS, and Pam McManus summarize the impact of Cigna’s site-of-care home-redirection program on pegfilgrastim effectiveness and the timing of administration in preventing complications from chemotherapy-induced neutropenia...

Lavanya Raj, MBBS, MS, and Pam...

06/05/2023

Journal of Clinical Pathways

Perspectives

Creating an Enabling Environment for Specialty Alternative Payment Models: A Potential Role for Philanthropy

04/12/2023

Lindee Goh , PhD;

Elizabeth Shaughnessy , MA;

Joel Ang , DPM, MS;

Elizabeth Shaughnessy and colleagues discuss how philanthropic support may be a helpful and overlooked resource to facilitate a better enabling environment for specialty APMs.

Elizabeth Shaughnessy and...

04/12/2023

Journal of Clinical Pathways

Research Reports

Bone-Modifying Agent Utilization: An Analysis in Patients With Metastatic Cancer and Bone Involvement at an NCI-Designated Cancer Center

04/12/2023

Julie Gralow , MD, FACP, FASCO;

Micah Tratt ;

Keith D. Eaton , MD, PhD;

Poorni M. Manohar , MD;

Kyle E. Bastys ;

Manohar et al investigate the cost of utilizing bone-modifying agents in the treatment of patients with metastatic cancer and bone involvement at a National Cancer Institute–designated cancer center.

Manohar et al investigate the...

04/12/2023

Journal of Clinical Pathways

OCPC: In Session

Patient Perspectives About Cancer Clinical Pathways and Care Coordination

04/11/2023

Deborah E. Collyar ;

Deborah E. Collyar discusses how patients feel through their cancer experience and suggests ways to incorporate important components like social determinants of health; diversity, equity, and inclusion strategies; and cost considerations so...

Deborah E. Collyar discusses how...

04/11/2023

Journal of Clinical Pathways

Research Reports

Belief in Research, Religious Coping, and Willingness to Participate in Clinical Trials Among African American Patients With Hematologic Malignancies: A Pilot Study

02/06/2023

Jennifer L. Waller , PhD;

Irina Shishkina , BSN;

Marjorie E. Petty , PhD, MSN;

Nita Maihle , PhD;

Lufei Young , PhD, RN, APRN-NP;

Cynthia Chernecky , PhD, RN, AOCN, FAAN;

Julie Zadinsky , PhD, MSS, RN, CIP;

Jean Pawl , PhD, RN, OCN, CNE;

Petty et al evaluated the belief in research, religious coping, and willingness to participate in clinical trials by African American patients with hematologic malignancies. The basis for their exploration is that, while the AA population has...

Petty et al evaluated the belief...

02/06/2023

Journal of Clinical Pathways

Research Reports

Post–COVID-19 Syndrome Clinical Pathway for the US Veterans Health Administration

02/06/2023

Allison M. Gustavson , DPT, PhD;

Johnson Vachachira , NP;

Claudia L. Campos , MD;

Jacob B. Lindheimer , PhD;

Kristina Crothers , MD;

Omar Awan , MD;

Carrie B. May , PsyD;

Cristina Nguyen , BS;

Courtney Sedillo , MSN, FNP-C;

Francis J. Miller Jr., MD;

Lindheimer et al summarize the stepwise diagnostic approach for patients presenting with PCS dyspnea and/or cough in primary care and highlight teleconsultation and telerehabilitation as opportunities to reach those in rural areas or with...

Lindheimer et al summarize the...

02/06/2023

Journal of Clinical Pathways

Research Reports

Impact of Shared Decision-Making and Patient Decision Aids on Health Care Cost and Utilization in the US: A Systematic Review

12/05/2022

Theresa Schmidt , MA, PMP, CSPO;

Robert W. Dubois , MD, PhD;

Jacqlyn Riposo , MBA;

Kimberly Westrich , MA;

Palak Patel , MHA;

Tom Valuck , MD, JD;

Brittany Perkins , MPH;

The authors summarize evidence on the impact of shared decision-making as a process, patient decision aids as tools to support decision-making, and the combination of shared decision-making and patient decision aids on cost, utilization, and...

The authors summarize evidence...

12/05/2022

Journal of Clinical Pathways

Research Reports

Measuring Telehealth Quality in Cancer Care: We Don’t Know What We Don’t Know

11/15/2022

Tom Valuck , MD, JD;

David Blaisdell , BA;

The authors evaluate key quality considerations related to the use of telehealth in oncology in the context of the National Committee for Quality Assurance and the National Quality Forum's recommendations and discuss strategies to enhance...

The authors evaluate key quality...

11/15/2022

Journal of Clinical Pathways

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Feature

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products